Clinical Cancer Research Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denis, F.
Right arrow Articles by Bougnoux, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denis, F.
Right arrow Articles by Bougnoux, P.
Clinical Cancer Research Vol. 9, 4546-4552, October 1, 2003
© 2003 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Changes in Tumor Vascularization after Irradiation, Anthracyclin, or Antiangiogenic Treatment in Nitrosomethyl Ureas-Induced Rat Mammary Tumors

Fabrice Denis1, Séverine Colas, Linda Chami, Pascal Louisot, Olivier le Floch, François Tranquart and Philippe Bougnoux

Institut National de la Santé et de la Recherche Médicale E 0211 [F. D., S. C., P. L., O. l. F., P. B.], and Institut National de la Santé et de la Recherche Médicale U316 [L. C., F. T.], IFR 120, CHU Bretonneau, Tours, France

Purpose: Changes in tumor vascularization may be involved in tumor regression after anticancer treatments. We therefore studied the relationship between tumor vascularization and tumor response according to treatment by irradiation (RT), epirubicin (EPI), or antiangiogenic agent TNP-470 in a nitrosomethyl-ureas-induced rat mammary tumor model by measuring the changes in tumor blood flow using high-frequency Power-Doppler sonography.

Experimental Design: Mammary tumors were induced in female Sprague-Dawley rats by a single s.c. injection of nitrosomethyl-ureas. After tumor areas reached 2 cm2, the animals received four weekly injections of epirubicin (EPI group), or a single fraction of 18 Gy (RT group), or six injections of TNP-470 within 12 days (TNP group), or both (RT combined with TNP-470, RT+TNP group). Power-Doppler sonography quantification of tumor vascularization (PDI) was performed before and 12 days after initiation of treatment. Tumor shrinkage was later evaluated and compared with the early changes in PDI values.

Results: Compared with the control group, EPI induced an arrest in tumor growth. A similar effect was obtained with TNP-470. There was a decrease in tumor area after RT, but administration of TNP-470 combined with RT did not further enhance this effect. Changes in tumor area paralleled changes in PDI in the EPI group. Furthermore, changes in PDI 7 days after RT were associated with further tumor change in the RT groups, whereas they were independent of the antitumor effect of TNP-470.

Conclusions: Changes in functional tumor vascularization evolution appeared to be closely associated with tumor regression after anticancer treatment.




This article has been cited by other articles:


Home page
JNMHome page
A. van Waarde, K. Shiba, J. R. de Jong, K. Ishiwata, R. A. Dierckx, and P. H. Elsinga
Rapid Reduction of {sigma}1-Receptor Binding and 18F-FDG Uptake in Rat Gliomas After In Vivo Treatment with Doxorubicin
J. Nucl. Med., August 1, 2007; 48(8): 1320 - 1326.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Colas, K. Maheo, F. Denis, C. Goupille, C. Hoinard, P. Champeroux, F. Tranquart, and P. Bougnoux
Sensitization by dietary docosahexaenoic Acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization.
Clin. Cancer Res., October 1, 2006; 12(19): 5879 - 5886.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. M. Fenton, S. F. Paoni, and I. Ding
Pathophysiological Effects of Vascular Endothelial Growth Factor Receptor-2-Blocking Antibody plus Fractionated Radiotherapy on Murine Mammary Tumors
Cancer Res., August 15, 2004; 64(16): 5712 - 5719.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.